Molecular characterization of CD34+ human hematopoietic progenitor cells.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 7543291)

Published in Ann Hematol on June 01, 1995

Authors

W Knapp1, H Strobl, C Scheinecker, C Bello-Fernandez, O Majdic

Author Affiliations

1: Institute of Immunology, University of Vienna, Austria.

Articles by these authors

Cultured human Langerhans cells resemble lymphoid dendritic cells in phenotype and function. J Invest Dermatol (1989) 2.63

A comprehensive and quantitative analysis of the major specificities in rabbit antithymocyte globulin preparations. Am J Transplant (2013) 2.39

Self-recognition of CD1 by gamma/delta T cells: implications for innate immunity. J Exp Med (2000) 2.30

CD1 molecule expression on human monocytes induced by granulocyte-macrophage colony-stimulating factor. J Immunol (1993) 2.19

Molecular characterization and functional analysis of the leukocyte surface protein CD31. J Immunol (1990) 2.07

Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes. J Immunol (1996) 1.99

A human Ia cytoplasmic determinant located on multiple forms of invariant chain (gamma, gamma 2, gamma 3). J Immunol (1984) 1.90

Urokinase plasminogen activator receptor, beta 2-integrins, and Src-kinases within a single receptor complex of human monocytes. J Exp Med (1995) 1.89

TGF-beta 1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors. J Immunol (1996) 1.87

Evidence of HLA-DR antigen biosynthesis by human keratinocytes in disease. J Exp Med (1984) 1.75

T cell stimulation via the erythrocyte receptor. Synergism between monoclonal antibodies and phorbol myristate acetate without changes of free cytoplasmic Ca++ levels. J Exp Med (1986) 1.68

Neutrophil granulocyte-committed cells can be driven to acquire dendritic cell characteristics. J Exp Med (1998) 1.54

Mac-1 (CD11b/CD18) and the urokinase receptor (CD87) form a functional unit on monocytic cells. Blood (1996) 1.52

CD27 expression by a distinct subpopulation of human B lymphocytes. Eur J Immunol (1990) 1.51

Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture. Blood (1992) 1.49

Lack of DNA synthesis among CD34+ cells in cord blood and in cytokine-mobilized blood. Br J Haematol (1996) 1.48

Recombinant human GM-CSF enhances T cell-mediated cytotoxic function after ABMT for hematological malignancies. Bone Marrow Transplant (1993) 1.45

Calcium pyrophosphate dihydrate crystal deposition disease of the temporomandibular joint. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1998) 1.44

Generation of human dendritic cells/Langerhans cells from circulating CD34+ hematopoietic progenitor cells. Blood (1996) 1.42

Antigenic analysis of human haemopoietic progenitor cells expressing the growth factor receptor c-kit. Br J Haematol (1992) 1.40

1995 directory for the human leukocyte clusters of differentiation. Transfusion (1996) 1.39

Mast cell typing: demonstration of a distinct hematopoietic cell type and evidence for immunophenotypic relationship to mononuclear phagocytes. Blood (1989) 1.33

MUC18/MCAM (CD146), an activation antigen of human T lymphocytes. J Immunol (1997) 1.32

IgM and IgG but not cytokine secretion is restricted to the CD27+ B lymphocyte subset. J Immunol (1992) 1.32

flt3 ligand in cooperation with transforming growth factor-beta1 potentiates in vitro development of Langerhans-type dendritic cells and allows single-cell dendritic cell cluster formation under serum-free conditions. Blood (1997) 1.31

Signal transduction in lymphocytic and myeloid cells via CD24, a new member of phosphoinositol-anchored membrane molecules. J Immunol (1990) 1.31

Ligation of E-cadherin on in vitro-generated immature Langerhans-type dendritic cells inhibits their maturation. Blood (2000) 1.28

Interleukin 3 activates human blood basophils via high-affinity binding sites. Proc Natl Acad Sci U S A (1989) 1.26

T cell activation-associated epitopes of CD147 in regulation of the T cell response, and their definition by antibody affinity and antigen density. Int Immunol (1999) 1.19

Identification of CD68+lin- peripheral blood cells with dendritic precursor characteristics. J Immunol (1998) 1.17

Interleukin 4 promotes expression of mast cell ICAM-1 antigen. Proc Natl Acad Sci U S A (1991) 1.13

TGF-beta 1 promotes in vitro generation of dendritic cells by protecting progenitor cells from apoptosis. J Immunol (1997) 1.13

Myeloid differentiation antigen defined by a monoclonal antibody. Blood (1981) 1.12

1,25-Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro. Exp Hematol (2000) 1.10

Failure to detect IL-3-binding sites on human mast cells. J Immunol (1990) 1.10

VIL-A1, a monoclonal antibody reactive with common acute lymphatic leukemia cells. Leuk Res (1982) 1.08

Initiation of the autologous mixed lymphocyte reaction requires the expression of costimulatory molecules B7-1 and B7-2 on human peripheral blood dendritic cells. J Immunol (1998) 1.08

Granulocyte activation via a binding site near the C-terminal region of complement receptor type 3 alpha-chain (CD11b) potentially involved in intramembrane complex formation with glycosylphosphatidylinositol-anchored Fc gamma RIIIB (CD16) molecules. J Immunol (1995) 1.07

Interaction of antithymocyte globulins with dendritic cell antigens. Am J Transplant (2010) 1.07

Activated human T lymphocytes express MHC class I heavy chains not associated with beta 2-microglobulin. J Exp Med (1990) 1.05

A rapid and simple immunoperoxidase staining procedure for blood and bone marrow samples. J Immunol Methods (1986) 1.05

Analysis of T cell activation with a non-mitogenic anti CD3 antibody and the phorbol ester TPA. Clin Exp Immunol (1985) 1.05

T cell stimulation via CD47: agonistic and antagonistic effects of CD47 monoclonal antibody 1/1A4. J Immunol (1997) 1.04

Foxp3 expression in CD4+ T cells of patients with systemic lupus erythematosus: a comparative phenotypic analysis. Ann Rheum Dis (2007) 1.04

TGF-beta 1 is a potent inducer of human effector T cells. J Immunol (1994) 1.03

Monoclonal antibodies to human myelomonocyte differentiation antigens in the diagnosis of acute myeloid leukemia. Med Oncol Tumor Pharmacother (1984) 1.03

Kinetics of activation antigen expression by in vitro-stimulated human T lymphocytes. Cell Immunol (1985) 1.03

The Tie receptor tyrosine kinase is expressed by human hematopoietic progenitor cells and by a subset of megakaryocytic cells. Blood (1996) 1.03

Monocytes do not make mast cells when cultured in the presence of SCF. Characterization of the circulating mast cell progenitor as a c-kit+, CD34+, Ly-, CD14-, CD17-, colony-forming cell. J Immunol (1993) 1.03

Flow cytometric analysis of intracellular CD68 molecule expression in normal and malignant haemopoiesis. Br J Haematol (1995) 1.02

Shared antigenic determinants between human hemopoietic cells and nervous tissues and tumors. Acta Neuropathol (1985) 1.02

Human major group rhinoviruses downmodulate the accessory function of monocytes by inducing IL-10. J Clin Invest (1999) 1.02

Fas- and activation-induced apoptosis are reduced in human T cells preactivated in the presence of TGF-beta 1. J Immunol (1996) 1.01

Signaling and induction of enhanced cytoadhesiveness via the hematopoietic progenitor cell surface molecule CD34. Blood (1994) 1.01

Phenotype of human T cells expressing CD31, a molecule of the immunoglobulin supergene family. Immunology (1992) 1.01

Expression of Wiskott-Aldrich syndrome protein (WASP) gene during hematopoietic differentiation. Blood (1997) 0.99

Treg and lupus. Ann Rheum Dis (2010) 0.99

Further characterization of surface membrane structures expressed on human basophils and mast cells. Int Arch Allergy Appl Immunol (1990) 0.99

Cloning and molecular characterization of Dashurin encoded by C20orf116, a PCI-domain containing protein. Biochim Biophys Acta (2009) 0.99

Reference intervals for human peripheral blood lymphocyte subpopulations from 'healthy' young and aged subjects. Int Arch Allergy Immunol (1995) 0.98

IL-4 regulates c-kit proto-oncogene product expression in human mast and myeloid progenitor cells. J Immunol (1991) 0.98

Analysis of function-associated receptor molecules on peripheral blood and synovial fluid granulocytes from patients with rheumatoid and reactive arthritis. J Clin Immunol (1991) 0.97

Position and orientation independent transactivation by c-Myc. Cell Mol Biol Res (1994) 0.95

Myeloperoxidase expression in CD34+ normal human hematopoietic cells. Blood (1993) 0.94

Monoclonal antibodies to the carbohydrate structure Lewis(x) stimulate the adhesive activity of leukocyte integrin CD11b/CD18 (CR3, Mac-1, alpha m beta 2) on human granulocytes. J Leukoc Biol (1993) 0.93

Malignant histiocytosis with unusual features. Disseminated intravascular coagulation with severe hyperfibrinolysis, acute polyneuroradiculitis Guillain-Barré, and a unique chromosome abnormality. Cancer (1984) 0.91

Abatacept (CTLA-4IG) treatment reduces the migratory capacity of monocytes in patients with rheumatoid arthritis. Arthritis Rheum (2013) 0.91

Leukosialin (CD43)-major histocompatibility class I molecule interactions involved in spontaneous T cell conjugate formation. J Exp Med (1996) 0.90

M2, a novel myelomonocytic cell surface antigen and its distribution on leukemic cells. Int J Cancer (1984) 0.90

Regulation of interleukin-4 production in human mononuclear cells. Eur J Immunol (1992) 0.90

Transforming growth factor-beta inhibits IL-4 and IFN-gamma production by stimulated human T cells. Int Immunol (1994) 0.90

CD99 engagement on human peripheral blood T cells results in TCR/CD3-dependent cellular activation and allows for Th1-restricted cytokine production. J Immunol (1998) 0.90

Functional involvement of E-cadherin in TGF-beta 1-induced cell cluster formation of in vitro developing human Langerhans-type dendritic cells. J Immunol (2000) 0.90

Monoclonal antibodies to the structural glycoprotein of tick-borne encephalitis virus. Infect Immun (1982) 0.89

A phase I clinical trial of recombinant interleukin 2 following high dose chemo-radiotherapy for haematological malignancy: applicability to the elimination of minimal residual disease. Br J Cancer (1989) 0.88

Diagnostic quality of dynamic high-resolution ultrasonography of the TMJ--a pilot study. Int J Oral Maxillofac Surg (2005) 0.87

Cell lineage heterogeneity in blast crisis of chronic myeloid leukaemia. Br J Haematol (1985) 0.87

The diagnostic value of ultrasonography to detect occult lymph node involvement at different levels in patients with squamous cell carcinoma in the maxillofacial region. Int J Oral Maxillofac Surg (2003) 0.86

Ultrasonographic cross-sectional characteristics of muscles of the head and neck. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1999) 0.86

Typing of leukemic cells with monoclonal antibodies. Ann N Y Acad Sci (1983) 0.86

Flow cytometric analysis of cell-surface and intracellular antigens in leukemia diagnosis. Cytometry (1994) 0.86